Concepedia

Author

Inge R. Konings

Amsterdam UMC Location Vrije Universiteit AmsterdamORCID

Also Known As

I. R. Konings, I.R. Konings, I.R.H.M. Konings, Inge Konings, Inge R H M Konings, Inge R. H. M. Konings, Inge R. Konings, Inge R.H.M. Konings, Inge RHM Konings, Inge RHM. Konings

63

Publications

1.5K

Citations

21

H-Index

30

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit AmsterdamAmsterdam University Medical CentersThe Netherlands Cancer InstituteCancer Center AmsterdamVrije Universiteit Amsterdam
IR

About

Inge R. Konings is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

204

2

Health Sciences

3

3

152

3

Nursing

2

2

63

4

Cell Biology

1

1

20

5

Obstetrics

1

1

89

Inge R. Konings

×

25

Publications

1.2K

Citations

19

H-Index

YearCitations

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands

Christel J.M. de Blok, Chantal M Wiepjes, Nienke M. Nota,

BMJ

2019

346

Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).

Gabe S. Sonke, Annemiek van Ommen‐Nijhof, Noor Wortelboer,

Journal of Clinical Oncology

2023

89

Five new cases of breast cancer in transsexual persons

Louis Gooren, Mindy A Bowers, Paul Lips,

Andrologia

2015

85

Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer

Kathelijn S. Versteeg, S. Blauwhoff-Buskermolen, Laurien M. Buffart,

The Oncologist

2017

81

‘Oncokompas’, a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors

Heleen C. Melissant, Irma M. Verdonck‐de Leeuw, Birgit I. Lissenberg‐Witte,

Acta Oncologica

2018

76

Burden of early, advanced and metastatic breast cancer in The Netherlands

Gerard T. Vondeling, Gisela L. G. Menezes, Evgeni Dvortsin,

BMC Cancer

2018

68

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

Annemiek van Ommen‐Nijhof, Inge R. Konings, Clementine J.J. van Zeijl,

BMC Cancer

2018

66

Tailoring exercise interventions to comorbidities and treatment-induced adverse effects in patients with early stage breast cancer undergoing chemotherapy: a framework to support clinical decisions

Marike van der Leeden, Rosalie J. Huijsmans, Edwin Geleijn,

Disability and Rehabilitation

2017

57

Physical problems, functional limitations, and preferences for physical therapist-guided exercise programs among Dutch patients with metastatic breast cancer: a mixed methods study

Marieke R. ten Tusscher, Wim G Groen, Edwin Geleijn,

Supportive Care in Cancer

2019

46

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes

Tessa G. Steenbruggen, Lars C. Steggink, Caroline Seynaeve,

JAMA Oncology

2020

31

Page 1